Skip to main content
Journal cover image

"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.

Publication ,  Journal Article
Fridman, I; Ubel, PA; Blumenthal-Barby, J; England, CV; Currier, JS; Eyal, N; Freedberg, KA; Halpern, SD; Kelley, CF; Kuritzkes, DR; Le, CN ...
Published in: AIDS Behav
July 2020

Many people living with HIV (PLWHIV) state that they would be willing to take significant risks to be "cured" of the virus. However, how they interpret the word "cure" in this context is not clear. We used a randomized survey to examine whether PLWHIV had a different willingness to take a hypothetical HIV medication if it causes flu-like symptoms, but provides: (a) cure, (b) remission that was labeled "cure", or (c) remission. PLWHIV (n = 454) were more willing to take a medication that provided a "cure" versus a "remission" if the side effects lasted less than 1 year. PLWHIV were more willing to take a medication that provided a remission that was labeled "cure" versus a "remission" (p = 0.01) if the side effects lasted 2 weeks. Clinicians and researchers should be aware of the impact of the word "cure" and ensure that PLWHIV fully understand the possible outcomes of their treatment options.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AIDS Behav

DOI

EISSN

1573-3254

Publication Date

July 2020

Volume

24

Issue

7

Start / End Page

2054 / 2061

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Research Personnel
  • Public Health
  • Patients
  • Middle Aged
  • Male
  • Intention
  • Humans
  • HIV Infections
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fridman, I., Ubel, P. A., Blumenthal-Barby, J., England, C. V., Currier, J. S., Eyal, N., … Scherr, K. A. (2020). "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication. AIDS Behav, 24(7), 2054–2061. https://doi.org/10.1007/s10461-019-02769-1
Fridman, Ilona, Peter A. Ubel, Jennifer Blumenthal-Barby, Cameron V. England, Judith S. Currier, Nir Eyal, Kenneth A. Freedberg, et al. “"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.AIDS Behav 24, no. 7 (July 2020): 2054–61. https://doi.org/10.1007/s10461-019-02769-1.
Fridman I, Ubel PA, Blumenthal-Barby J, England CV, Currier JS, Eyal N, et al. "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication. AIDS Behav. 2020 Jul;24(7):2054–61.
Fridman, Ilona, et al. “"Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication.AIDS Behav, vol. 24, no. 7, July 2020, pp. 2054–61. Pubmed, doi:10.1007/s10461-019-02769-1.
Fridman I, Ubel PA, Blumenthal-Barby J, England CV, Currier JS, Eyal N, Freedberg KA, Halpern SD, Kelley CF, Kuritzkes DR, Le CN, Lennox JL, Pollak KI, Zikmund-Fisher BJ, Scherr KA. "Cure" Versus "Clinical Remission": The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication. AIDS Behav. 2020 Jul;24(7):2054–2061.
Journal cover image

Published In

AIDS Behav

DOI

EISSN

1573-3254

Publication Date

July 2020

Volume

24

Issue

7

Start / End Page

2054 / 2061

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Research Personnel
  • Public Health
  • Patients
  • Middle Aged
  • Male
  • Intention
  • Humans
  • HIV Infections
  • Female